BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG
383 results:

  • 1. Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer.
    Kawano T; Englisch C; Hisada Y; Paul D; Archibald S; Grover S; Pabinger I; Ay C; Mackman N
    Thromb Res; 2024 May; 237():23-30. PubMed ID: 38547690
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TUMOR MARKERS EXPRESSION LEVELS IN gastric cancer PATIENT'S PERIPHERAL BLOOD BY RT-PCR ASSESSMENT.
    Kawakami GDS; Pereira MA; Kubrusly MS; Carrasco AGM; Ramos MFKP; Ribeiro Júnior U
    Arq Bras Cir Dig; 2024; 36():e1789. PubMed ID: 38324850
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union.
    Wyrwicz L; Rodríguez Sánchez CA; Sánchez-Rovira P; Lewis S; Sandschafer D; San T
    Future Oncol; 2024 Apr; 20(13):821-832. PubMed ID: 38305004
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.
    McCarthy G; Young K; Madin-Warburton M; Mantaian T; Brook E; Metcalfe K; Mikelson J; Xu R; Seyla-Hammer C; Aguiar-Ibáñez R; Amonkar M
    J Med Econ; 2024; 27(1):279-291. PubMed ID: 38293714
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Antral plexiform fibromyxoma: case report of a rare mesenchymal neoplasm.
    Oliveira Dos Santos CE; Malaman D; Arciniegas Sanmartin ID; Aleixo P; Lopes CV; Pereira-Lima JC
    Rev Gastroenterol Peru; 2023; 43(4):364-367. PubMed ID: 38228303
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. New developments and standard of care in the management of advanced gastric cancer.
    Depotte L; Palle J; Rasola C; Broudin C; Afrăsânie VA; Mariani A; Zaanan A
    Clin Res Hepatol Gastroenterol; 2024 Jan; 48(1):102245. PubMed ID: 37952913
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.
    Pace A; Scirocchi F; Napoletano C; Zizzari IG; Po A; Megiorni F; Asquino A; Pontecorvi P; Rahimi H; Marchese C; Ferretti E; Nuti M; Rughetti A
    J Transl Med; 2023 Sep; 21(1):626. PubMed ID: 37715207
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tiliroside Combined with Anti-muc1 Monoclonal Antibody as Promising Anti-cancer Strategy in AGS cancer Cells.
    Radziejewska I; Supruniuk K; Jakimiuk K; Tomczyk M; Bielawska A; Galicka A
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685842
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Model for gastric cancer Risk Prediction Based on
    Nguyen NT; Dang NDT; Vu QV; Dang AK; Ta TV
    In Vivo; 2023; 37(5):2347-2356. PubMed ID: 37652501
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
    Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
    Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Dissecting the genetic heterogeneity of gastric cancer.
    Hess T; Maj C; Gehlen J; Borisov O; Haas SL; Gockel I; Vieth M; Piessen G; Alakus H; Vashist Y; Pereira C; Knapp M; Schüller V; Quaas A; Grabsch HI; Trautmann J; Malecka-Wojciesko E; Mokrowiecka A; Speller J; Mayr A; Schröder J; Hillmer AM; Heider D; Lordick F; Pérez-Aísa Á; Campo R; Espinel J; Geijo F; Thomson C; Bujanda L; Sopeña F; Lanas Á; Pellisé M; Pauligk C; Goetze TO; Zelck C; Reingruber J; Hassanin E; Elbe P; Alsabeah S; Lindblad M; Nilsson M; Kreuser N; Thieme R; Tavano F; Pastorino R; Arzani D; Persiani R; Jung JO; Nienhüser H; Ott K; Schumann RR; Kumpf O; Burock S; Arndt V; Jakubowska A; Ławniczak M; Moreno V; Martín V; Kogevinas M; Pollán M; Dąbrowska J; Salas A; Cussenot O; Boland-Auge A; Daian D; Deleuze JF; Salvi E; Teder-Laving M; Tomasello G; Ratti M; Senti C; De Re V; Steffan A; Hölscher AH; Messerle K; Bruns CJ; Sīviņš A; Bogdanova I; Skieceviciene J; Arstikyte J; Moehler M; Lang H; Grimminger PP; Kruschewski M; Vassos N; Schildberg C; Lingohr P; Ridwelski K; Lippert H; Fricker N; Krawitz P; Hoffmann P; Nöthen MM; Veits L; Izbicki JR; Mostowska A; Martinón-Torres F; Cusi D; Adolfsson R; Cancel-Tassin G; Höblinger A; Rodermann E; Ludwig M; Keller G; Metspalu A; Brenner H; Heller J; Neef M; Schepke M; Dumoulin FL; Hamann L; Cannizzaro R; Ghidini M; Plaßmann D; Geppert M; Malfertheiner P; Gehlen O; Skoczylas T; Majewski M; Lubiński J; Palmieri O; Boccia S; Latiano A; Aragones N; Schmidt T; Dinis-Ribeiro M; Medeiros R; Al-Batran SE; Leja M; Kupcinskas J; García-González MA; Venerito M; Schumacher J
    EBioMedicine; 2023 Jun; 92():104616. PubMed ID: 37209533
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [A case of extensive digestive tract metastasis from invasive lobular carcinoma of the breast].
    Sakata N; Takeuchi Y; Matsunaga K; Nakamura H; Nakamura J; Sato K; Yonemitsu N; Sakata Y; Esaki M
    Nihon Shokakibyo Gakkai Zasshi; 2023; 120(5):416-422. PubMed ID: 37183035
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A systematic review of clinical trials of treatment regimens in HER2-amplified metastatic colorectal cancer.
    Sur D; Lungulescu C; Dumitrescu EA; Afrăsânie V; Spînu Ș; Lungulescu CV; Schmoll HJ
    Expert Rev Anticancer Ther; 2023 Jun; 23(6):633-641. PubMed ID: 37127555
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Accurate Capture and Identification of Exosomes: Nanoarchitecture of the MXene Heterostructure/Engineered Lipid Layer.
    Nie Y; Wang P; Wang S; Ma Q; Su X
    ACS Sens; 2023 Apr; 8(4):1850-1857. PubMed ID: 37114431
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cross-phenotype association analysis of gastric cancer: in-silico functional annotation based on the disease-gene network.
    Lee S; Yang HK; Lee HJ; Park DJ; Kong SH; Park SK
    Gastric Cancer; 2023 Jul; 26(4):517-527. PubMed ID: 36995485
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Immunotherapy in Hepatogastroenterology - update 2022: efficacy and immune-related adverse events].
    Krimmel L; Quante M; Bengsch B
    Dtsch Med Wochenschr; 2023 Mar; 148(6):294-300. PubMed ID: 36878227
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gastroblastoma mimics the embryonic mesenchyme of the foregut: a case report.
    Sugimoto R; Uesugi N; Yamada N; Osakabe M; Baba S; Yanagawa N; Akiyama Y; Habano W; Sasaki A; Oda Y; Sugai T
    Diagn Pathol; 2023 Feb; 18(1):24. PubMed ID: 36803776
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT.
    Chen K; Xu J; Tong YL; Yan JF; Pan Y; Wang WJ; Zheng L; Zheng XX; Hu C; Hu X; Shen X; Chen W
    Cell Death Dis; 2023 Feb; 14(2):115. PubMed ID: 36781842
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
    Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
    [No Abstract]    [Full Text] [Related]  

  • 20. [Immunotherapy in advanced gastric cancer].
    Zaanan A
    Bull Cancer; 2022 Oct; 109(10):1066-1072. PubMed ID: 36055806
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 20.